Ofloxacin in the treatment of lower respiratory tract infections: report of a prospective, comparative trial. The subjects were 241 patients with lower respiratory tract infections treated at two medical centers in Austria 161 of the patients were evaluated clinically and, of these, 69 were evaluated bacteriologically. The patients were randomly assigned to receive ofloxacin (n = 101) or a comparison drug (doxycycline [n = 27] or amoxicillin-clavulanate [n = 33]). The mean age of patients in the ofloxacin group was 61 years